51 Million-Person Study Finds COVID-19 “Vaccines” Increase Risk Of Respiratory Infections By Up To 559%

An enormous landmark study published in the International Journal of Infectious Diseases, covering every single resident in South Korea — all 51.6 million people — has delivered a striking population-level signal suggestive of vaccine-acquired immunodeficiency syndrome (VAIDS).

This massive dataset shows a consistent dose-dependent pattern: the more COVID-19 “vaccines” a person received, the higher their risk of developing the common cold and upper-respiratory infections. Increases in pneumonia and tuberculosis were identified in stratified analyses by age and infection status. Children ages 0-19 suffered the most.

Study Overview

  • Population: Entire national cohort of South Korea (N = 51,645,564).
  • Analytic cohort: 39,447,030 individuals with complete vaccination + infection records.
  • Observation period: June 1 2023 – September 30 2024.
  • Exposure: Total number of COVID-19 doses.
  • Outcomes: Seven major respiratory diseases — upper-respiratory infection (URI), pneumonia, influenza-like illness (ILI), common cold, scarlet fever, pertussis, and tuberculosis.
  • Covariate adjustments: age, sex, income level, Charlson comorbidity index, prior COVID-19 infection and severity, epidemic phase, and time since last vaccination.

Critical note: the “unvaccinated” reference group included individuals who had received one dose, inflating its infection rate and making the true vaccine-associated risk likely far higher than reported.

Keep reading